Nonoperating Income (Expense) in USD of INTEGRATED BIOPHARMA INC from Q4 2010 to 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
INTEGRATED BIOPHARMA INC quarterly/annual Nonoperating Income (Expense) history and change rate from Q4 2010 to 2025.
  • INTEGRATED BIOPHARMA INC Nonoperating Income (Expense) for the quarter ending 31 Mar 2025 was $39K.
  • INTEGRATED BIOPHARMA INC annual Nonoperating Income (Expense) for 2025 was $42K, a 147% increase from 2024.
  • INTEGRATED BIOPHARMA INC annual Nonoperating Income (Expense) for 2024 was $17K.
  • INTEGRATED BIOPHARMA INC annual Nonoperating Income (Expense) for 2023 was -$20K, a 86.5% increase from 2022.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Change (%)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Change (%)

INTEGRATED BIOPHARMA INC Quarterly Nonoperating Income (Expense) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $39K +$42K 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025
Q4 2024 -$17K -$17K 01 Oct 2024 31 Dec 2024 10-Q 13 Feb 2025
Q2 2024 $17K $12K +$8K +200% 01 Apr 2024 30 Jun 2024 10-K 23 Sep 2025
Q1 2024 $9K -$3K -$5K -250% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025
Q4 2023 $14K $0 +$12K 01 Oct 2023 31 Dec 2023 10-Q 13 Feb 2025
Q3 2023 $2K $8K +$22K 01 Jul 2023 30 Sep 2023 10-Q 09 Nov 2023
Q2 2023 -$20K $4K +$35K 01 Apr 2023 30 Jun 2023 10-K 20 Sep 2024
Q1 2023 -$55K $2K +$34K 01 Jan 2023 31 Mar 2023 10-Q 10 May 2024
Q4 2022 -$89K -$12K +$27K +69.2% 01 Oct 2022 31 Dec 2022 10-Q 12 Feb 2024
Q3 2022 -$116K -$14K +$32K +69.6% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023
Q2 2022 -$148K -$31K -$1.66M -102% 01 Apr 2022 30 Jun 2022 10-K 15 Sep 2023
Q1 2022 $1.52M -$32K -$19K -146% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023
Q4 2021 $1.53M -$39K +$76K +66.1% 01 Oct 2021 31 Dec 2021 10-Q 10 Feb 2023
Q3 2021 $1.46M -$46K -$5K -12.2% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022
Q2 2021 $1.46M $1.63M +$1.59M +3372% 01 Apr 2021 30 Jun 2021 10-K 13 Sep 2022
Q1 2021 -$122K -$13K -$56K -130% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022
Q4 2020 -$66K -$115K +$19K +14.2% 01 Oct 2020 31 Dec 2020 10-Q 10 Feb 2022
Q3 2020 -$85K -$41K +$86K +67.7% 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021
Q2 2020 -$171K $47K +$164K 01 Apr 2020 30 Jun 2020 10-K 02 Sep 2021
Q1 2020 -$335K $43K +$214K 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021
Q4 2019 -$549K -$134K +$49K +26.8% 01 Oct 2019 31 Dec 2019 10-Q 12 Feb 2021
Q3 2019 -$598K -$127K +$64K +33.5% 01 Jul 2019 30 Sep 2019 10-Q 12 Nov 2020
Q2 2019 -$662K -$117K -$239K -196% 01 Apr 2019 30 Jun 2019 10-K 23 Sep 2020
Q1 2019 -$423K -$171K -$2K -1.18% 01 Jan 2019 31 Mar 2019 10-Q 13 May 2020
Q4 2018 -$421K -$183K +$25K +12% 01 Oct 2018 31 Dec 2018 10-Q 12 Feb 2020
Q3 2018 -$446K -$191K +$243K +56% 01 Jul 2018 30 Sep 2018 10-Q 13 Nov 2019
Q2 2018 -$689K $122K 01 Apr 2018 30 Jun 2018 10-K 29 Aug 2019
Q1 2018 -$169K -$46K -37.4% 01 Jan 2018 31 Mar 2018 10-Q 15 May 2019
Q4 2017 -$208K +$368K +63.9% 01 Oct 2017 31 Dec 2017 10-Q 13 Feb 2019
Q3 2017 -$434K +$150K +25.7% 01 Jul 2017 30 Sep 2017 10-Q 09 Nov 2018
Q1 2017 -$123K +$240K +66.1% 01 Jan 2017 31 Mar 2017 10-Q 09 May 2018
Q4 2016 -$576K -$365K -173% 01 Oct 2016 31 Dec 2016 10-Q 09 Feb 2018
Q3 2016 -$584K -$368K -170% 01 Jul 2016 30 Sep 2016 10-Q 09 Nov 2017
Q1 2016 -$958K -$363K -$269K -286% 01 Jan 2016 31 Mar 2016 10-Q 10 May 2017
Q4 2015 -$689K -$211K -$426K -198% 01 Oct 2015 31 Dec 2015 10-Q 10 Feb 2017
Q3 2015 -$263K -$216K -$199K -1171% 01 Jul 2015 30 Sep 2015 10-Q 10 Nov 2016
Q2 2015 -$64K -$168K +$257K +60.5% 01 Apr 2015 30 Jun 2015 10-K 02 Sep 2016
Q1 2015 -$321K -$94K +$133K +58.6% 01 Jan 2015 31 Mar 2015 10-Q 13 May 2016
Q4 2014 -$454K $215K +$376K 01 Oct 2014 31 Dec 2014 10-Q 19 Feb 2016
Q3 2014 -$830K -$17K +$302K +94.7% 01 Jul 2014 30 Sep 2014 10-Q 05 Nov 2015
Q2 2014 -$1.13M -$425K -$653K -286% 01 Apr 2014 30 Jun 2014 10-K 04 Sep 2015
Q1 2014 -$479K -$227K +$465K +67.2% 01 Jan 2014 31 Mar 2014 10-Q 14 May 2014
Q4 2013 -$944K -$161K -$958K -120% 01 Oct 2013 31 Dec 2013 10-Q 17 Feb 2015
Q3 2013 $14K -$319K +$1.02M +76.2% 01 Jul 2013 30 Sep 2013 10-Q 07 Nov 2014
Q2 2013 -$1.01M $228K +$608K 01 Apr 2013 30 Jun 2013 10-K 08 Sep 2014
Q1 2013 -$1.61M -$692K -$401K -138% 01 Jan 2013 31 Mar 2013 10-Q 14 May 2014
Q4 2012 -$1.21M $797K +$2.08M 01 Oct 2012 31 Dec 2012 10-Q/A 13 Feb 2014
Q3 2012 -$3.29M -$1.34M -$1.09M -442% 01 Jul 2012 30 Sep 2012 10-Q 19 Nov 2012
Q2 2012 -$2.2M -$380K 01 Apr 2012 30 Jun 2012 10-K 15 Oct 2012
Q1 2012 -$291K +$222K +43.3% 01 Jan 2012 31 Mar 2012 10-Q 15 May 2013
Q4 2011 -$1.28M -$763K -148% 01 Oct 2011 31 Dec 2011 10-Q 19 Feb 2013
Q3 2011 -$247K 01 Jul 2011 30 Sep 2011 10-Q 19 Nov 2012
Q1 2011 -$513K 01 Jan 2011 31 Mar 2011 10-Q 21 May 2012
Q4 2010 -$515K 01 Oct 2010 31 Dec 2010 10-Q 21 Feb 2012

INTEGRATED BIOPHARMA INC Annual Nonoperating Income (Expense) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2025 $42K +$25K +147% 01 Jul 2024 30 Jun 2025 10-K 23 Sep 2025
2024 $17K +$37K 01 Jul 2023 30 Jun 2024 10-K 23 Sep 2025
2023 -$20K +$128K +86.5% 01 Jul 2022 30 Jun 2023 10-K 20 Sep 2024
2022 -$148K -$1.61M -110% 01 Jul 2021 30 Jun 2022 10-K 15 Sep 2023
2021 $1.46M +$1.63M 01 Jul 2020 30 Jun 2021 10-K 13 Sep 2022
2020 -$171K +$491K +74.2% 01 Jul 2019 30 Jun 2020 10-K 02 Sep 2021
2019 -$662K +$27K +3.92% 01 Jul 2018 30 Jun 2019 10-K 23 Sep 2020
2018 -$689K +$122K +15% 01 Jul 2017 30 Jun 2018 10-K 29 Aug 2019
2017 -$811K +$471K +36.7% 01 Apr 2017 31 Mar 2018 10-Q 09 May 2018
2016 -$1.28M -$1.22M -1903% 01 Apr 2016 31 Mar 2017 10-Q 09 May 2018
2015 -$64K +$1.07M +94.3% 01 Jul 2014 30 Jun 2015 10-K 02 Sep 2016
2014 -$1.13M -$126K -12.5% 01 Jul 2013 30 Jun 2014 10-K 04 Sep 2015
2013 -$1.01M +$1.19M +54.2% 01 Jul 2012 30 Jun 2013 10-K 08 Sep 2014
2012 -$2.2M -$302K -15.9% 01 Jul 2011 30 Jun 2012 10-K 15 Oct 2012
2011 -$1.89M 01 Jul 2010 30 Jun 2011 10-K 15 Oct 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.